1. Home
  2. IRWD vs DCGO Comparison

IRWD vs DCGO Comparison

Compare IRWD & DCGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRWD
  • DCGO
  • Stock Information
  • Founded
  • IRWD 1998
  • DCGO 2015
  • Country
  • IRWD United States
  • DCGO United States
  • Employees
  • IRWD N/A
  • DCGO N/A
  • Industry
  • IRWD Biotechnology: Pharmaceutical Preparations
  • DCGO Managed Health Care
  • Sector
  • IRWD Health Care
  • DCGO Health Care
  • Exchange
  • IRWD Nasdaq
  • DCGO Nasdaq
  • Market Cap
  • IRWD 150.9M
  • DCGO 138.7M
  • IPO Year
  • IRWD 2010
  • DCGO N/A
  • Fundamental
  • Price
  • IRWD $0.63
  • DCGO $1.50
  • Analyst Decision
  • IRWD Buy
  • DCGO Strong Buy
  • Analyst Count
  • IRWD 5
  • DCGO 4
  • Target Price
  • IRWD $4.94
  • DCGO $3.74
  • AVG Volume (30 Days)
  • IRWD 3.0M
  • DCGO 1.7M
  • Earning Date
  • IRWD 05-07-2025
  • DCGO 05-08-2025
  • Dividend Yield
  • IRWD N/A
  • DCGO N/A
  • EPS Growth
  • IRWD N/A
  • DCGO N/A
  • EPS
  • IRWD N/A
  • DCGO N/A
  • Revenue
  • IRWD $317,676,000.00
  • DCGO $520,500,658.00
  • Revenue This Year
  • IRWD N/A
  • DCGO N/A
  • Revenue Next Year
  • IRWD N/A
  • DCGO $4.08
  • P/E Ratio
  • IRWD N/A
  • DCGO N/A
  • Revenue Growth
  • IRWD N/A
  • DCGO N/A
  • 52 Week Low
  • IRWD $0.53
  • DCGO $1.23
  • 52 Week High
  • IRWD $7.11
  • DCGO $5.68
  • Technical
  • Relative Strength Index (RSI)
  • IRWD 39.10
  • DCGO 37.35
  • Support Level
  • IRWD $0.55
  • DCGO $1.32
  • Resistance Level
  • IRWD $0.65
  • DCGO $1.53
  • Average True Range (ATR)
  • IRWD 0.07
  • DCGO 0.09
  • MACD
  • IRWD 0.02
  • DCGO 0.03
  • Stochastic Oscillator
  • IRWD 37.04
  • DCGO 60.98

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

About DCGO DocGo Inc.

DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.

Share on Social Networks: